Synovial SarcomaSymptoms, Doctors, Treatments, Advances & More
Synovial Sarcoma Overview
Learn About Synovial Sarcoma
- Synovial sarcoma
- Synovial cell sarcoma
- Synovialosarcoma
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Synovial Sarcoma. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
Rockefeller Outpatient Pavilion
Sandra D'angelo is an Oncologist practicing medicine in New York, New York. Dr. D'angelo is rated as an Elite provider by MediFind in the treatment of Synovial Sarcoma. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Warren A. Chow is a board-certified UCI Health oncologist who specializes in melanoma and sarcomas. He serves as associate director for clinical services at the UCI Health Chao Family Comprehensive Cancer Center.He received his medical degree from Chicago Medical School at Rosalind Franklin University of Medicine and Science in North Chicago, Ill. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Next he received fellowship training in medical oncology, hematology and bone marrow transplantation at the City of Hope in Duarte, Calif., where he served nearly 30 years as a clinician and researcher conducting bench-to-bedside studies in both bone and soft-tissue sarcomas.The recipient of numerous research grants from the National Cancer Institute, the U.S. Food and Drug Administration, the Melanoma Research Foundation and many others, Chow has been the principal investigator on more than three dozen clinical trials. He is the author of more than 80 publications and four book chapters, and he serves on the editorial boards of the journalsPLOS ONE,F1000 ResearchandScientific Reports (Nature). Dr. Chow is rated as an Elite provider by MediFind in the treatment of Synovial Sarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, and Chondrosarcoma. Dr. Chow is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.
Summary: This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Leiomyosarcomas are a type sarcoma that can occur in any location in the body, such as the uterus or in the abdomen. Current standard treatment for leiomyosar...
Summary: This early phase I trial tests the safety and how well N-803 works in treating patients with synovial sarcoma (SS) or myxoid/round cell liposarcoma (MRCL) that is growing, spreading, or getting worse (progressive) after being treated with adoptive cellular therapy (ACT) using T-cell receptor therapy (T-CRT). Synovial sarcoma is a rare, slow-growing cancer that affects the soft tissues, like muscle...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

